ROBERT R RUFFOLO

CIK 1187308 · Sr. VP & Pres., Wyeth Research · last filed 2026-06-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

6

Total Filings

23

Lifetime Open-Market Net

-$7.68M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LBRX	Director	—	$28.42	—	$0	2	2026-06-05
ELTX	Director	—	$14.85	—	$0	3	2025-05-20
Sigilon Therapeutics, Inc. (SGTX) Delisted	Director	6,750	$22.47	$151.7K	-$69.9K	6	2023-08-11
Aridis Pharmaceuticals, Inc. (ARDS) Delisted	Director	—	$0.31	—	$0	3	2022-12-07
CervoMed Inc. (DFFN) Delisted	Director	—	$6.60	—	$0	3	2018-06-18
WYETH (WYEp) Delisted	Sr. VP & Pres., Wyeth Research	293,256	—	—	-$7.61M	6	2008-03-04

Recent Filings · Page 3 of 3

23 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2007-04-30	WYETH (WYEp) Delisted	Grant (A)	—	$0	EDGAR
2007-02-28	WYETH (WYEp) Delisted	Mixed	+93,769	-$123.1K	EDGAR
2007-01-29	WYETH (WYEp) Delisted	Mixed	+1,243	-$1.4K	EDGAR

Showing 21–23 of 23

Prev Page 3 of 3

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.